Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 7/4/2025

Torsemide in Hypertension Management

Introduction to Torsemide

  • The American College of Cardiology (ACC) and American Heart Association (AHA) guidelines recognize torsemide as an effective loop diuretic for heart failure management, with a longer duration of action (12-16 hours) compared to furosemide (6-8 hours) 1

Efficacy and Dosage

  • The American College of Cardiology recommends torsemide at 10-20 mg daily for significant weight reduction in patients with heart failure, producing -1.62 kg with 10 mg and -1.30 kg with 20 mg after 7 days 1
  • When switching from furosemide to torsemide, approximately half the furosemide dose should be used (10-20 mg torsemide ≈ 20-40 mg furosemide), due to torsemide's higher bioavailability (>80%) and longer elimination half-life (3-4 hours) 2

Comparison with Other Diuretics

  • Torsemide has a longer duration of action and more consistent absorption compared to furosemide, which may provide more reliable blood pressure control in certain patients 2

Treatment Strategies

  • In resistant hypertension, torsemide may be particularly useful due to its consistent bioavailability and longer duration of action 3
  • Combining torsemide with ACE inhibitors, ARBs, or aldosterone antagonists helps prevent electrolyte depletion and enhances blood pressure control 4

Administration and Monitoring

  • Bedtime administration of torsemide provides significantly greater BP reduction compared to morning dosing, and should be considered for maximizing antihypertensive effect 1